Pfizer

EMA Backs Eight New Medicines, Turns Down Drugs From Nektar & Vanda
RAPS.org
Sat, 07/22/17 - 12:23 pm
EMA
Europe
Pfizer
Bavencio
Novartis
Rydapt
Lexicon Pharmaceuticals
Xermelo
Vanda
Fanaptum
Nektar
Onzeald
Daiichi Sankyo
With Viagra and Lyrica fading, analysts downgrade Pfizer due to mounting challenges
Fierce Pharma
Fri, 07/21/17 - 03:17 pm
Pfizer
Viagra
Lyrica
patents
Pfizer CEO: The Future Of American Innovation Rests On A Competitive U.S. Tax Policy
Forbes
Thu, 07/20/17 - 05:58 pm
Pfizer
Pharma CEOs
innovation
Ian Read
How did Johnson & Johnson beat back Remicade's biosim? Call it the art of the deal
Fierce Pharma
Thu, 07/20/17 - 11:18 am
JNJ
Remicade
biosimilars
Pfizer
Inflectra
Pfizer Is Set to Lose Its No. 1 Spot Among Drugmakers: Here's Why It Doesn't Matter
Motley Fool
Sun, 07/16/17 - 03:49 pm
Novartis
Pfizer
GlaxoSmithKline woos Pfizer medicinal sciences chief Tony Wood to high-level R&D job
Endpoints
Fri, 07/14/17 - 07:52 am
GSK
Pfizer
Tony Wood
R&D
Years after accelerated approval debacle, FDA panel backs Pfizer's Mylotarg
Fierce Pharma
Wed, 07/12/17 - 12:05 am
FDA
Pfizer
Mylotarg
acute myeloid leukemia
Lilly revs up to challenge Pfizer, Novartis in breast cancer with abemaciclib 'priority' nod
Fierce Pharma
Tue, 07/11/17 - 09:56 am
Eli Lilly
Pfizer
Novartis
breast cancer
abemaciclib
Ibrance
Kisqali
[video]How Portola Is Looking to Change the Anticoagulant Game
Motley Fool
Tue, 07/11/17 - 09:55 am
Portola Pharmaceuticals
anticoagulants
Bevyxxa
JNJ
Pfizer
These 5 Cancer Drugs Will Be the Biggest Winners 5 Years From Now
Motley Fool
Mon, 07/10/17 - 11:34 pm
Celgene
Revlimid
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
AbbVie
JNJ
Imbruvica
Pfizer
Ibrance
cancer
Pfizer Exits Brazil Venture
TheStreet.com
Thu, 07/6/17 - 11:20 pm
Pfizer
Brazil
Laboratorio Teuto Brasileiro S.A
generics
Industry paid $8.2B to docs, hospitals last year
BioPharma Dive
Wed, 07/5/17 - 07:27 pm
physicians
physician payments
Roche
Novartis
Pfizer
Pfizer to open new R&D facility in Missouri
BioPharma Dive
Sat, 07/1/17 - 09:17 am
Pfizer
R&D
Missouri
Pfizer’s Geographical Performance in 1Q17
Market Realist
Wed, 06/28/17 - 09:29 am
Pfizer
FDA Rejects Pfizer's Anemia Drug Biosimilar
Xtalks
Tue, 06/27/17 - 11:50 pm
FDA
Pfizer
biosimilars
Epogen
Amgen
anemia
Pfizer preps new hires as it begins building a new, $200M R&D campus
Endpoints
Tue, 06/27/17 - 10:35 am
Pfizer
R&D
Boston
Bay Area
Pfizer Fueling Growth Of Competitors' Pipelines
Forbes
Tue, 06/27/17 - 10:02 am
Pfizer
R&D
Clovis Oncology
Puma Biotechnology
Bioventus
Shire
AstraZeneca
Pfizer’s Xeljanz: Results from the ORAL Strategy
Market Realist
Mon, 06/26/17 - 10:38 pm
Pfizer
Xeljanz
rheumatoid arthritis
FDA rejects Pfizer's Epogen biosimilar for the second time
Fierce Pharma
Fri, 06/23/17 - 09:50 am
FDA
Pfizer
biosimilars
Epogen
Pfizer kicks off human testing with maternal GBS vaccine
Fierce Pharma
Tue, 06/20/17 - 11:05 pm
Pfizer
vaccines
Group B Strep
PF-06760805

Pages